臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 总笔数 :2853522
	造访人次 : 45200811 在线人数 : 755 教育部委托研究计画计画执行:国立台湾大学图书馆

搜寻范围

进阶搜寻

登入

管理

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"zeaiter a"的相关文件

回到依作者浏览
依题名排序	依日期排序

显示项目 1-10 / 10 (共1页)
1
每页显示[10|25|50]项目

机构	日期	题名	作者
臺大學術典藏	2020-05-26T09:26:49Z	Alectinib in crizotinib-refractory alk-rearranged non-small-cell lung cancer: A phase II global study	Spira A; Bordogna W; Balas B; Morcos P.N; Monnet A; Zeaiter A; Kim D.-W.; Kim D.-W.;Zeaiter A;Monnet A;Morcos P.N;Balas B;Bordogna W;Spira A;Mekhail T;Ramirez S.V;Bearz A;Moro-Sibilot D;Lena H;Hughes B;Chih-Hsin Yang;Govindan R;De Petris L;Ahn J.S;Ou S.-H.I; Ou S.-H.I; Ahn J.S; De Petris L; Govindan R; CHIH-HSIN YANG; Hughes B; Lena H; Moro-Sibilot D; Bearz A; Ramirez S.V; Mekhail T
臺大學術典藏	2020-05-26T09:26:49Z	Alectinib in crizotinib-refractory alk-rearranged non-small-cell lung cancer: A phase II global study	Spira A; Bordogna W; Balas B; Morcos P.N; Monnet A; Zeaiter A; Kim D.-W.; Kim D.-W.;Zeaiter A;Monnet A;Morcos P.N;Balas B;Bordogna W;Spira A;Mekhail T;Ramirez S.V;Bearz A;Moro-Sibilot D;Lena H;Hughes B;Chih-Hsin Yang;Govindan R;De Petris L;Ahn J.S;Ou S.-H.I; Ou S.-H.I; Ahn J.S; De Petris L; Govindan R; CHIH-HSIN YANG; Hughes B; Lena H; Moro-Sibilot D; Bearz A; Ramirez S.V; Mekhail T
臺大學術典藏	2020-05-26T09:26:43Z	Pooled analysis of CNS response to alectinib in two studies of pretreated patients with ALK-positive non-small-cell lung cancer	Ou S.-H.I.;Zeaiter A;Golding S;Bordogna W;Han J.-Y;Chih-Hsin Yang;Tessmer A;Dansin E;De Pas T;Crino L;Duruisseaux M;Moro-Sibilot D.L;Chiappori A;Kim D.-W;De Petris L;Camidge D.R;Socinski M.A;Gandhi L;Govindan R;Shaw A.T;Gadgeel S.M; Gadgeel S.M; Shaw A.T; Govindan R; Gandhi L; Socinski M.A; Camidge D.R; De Petris L; Kim D.-W; Chiappori A; Moro-Sibilot D.L; Duruisseaux M; Crino L; De Pas T; Dansin E; Tessmer A; CHIH-HSIN YANG; Han J.-Y; Bordogna W; Golding S; Zeaiter A; Ou S.-H.I.
臺大學術典藏	2020-05-26T09:26:43Z	Pooled analysis of CNS response to alectinib in two studies of pretreated patients with ALK-positive non-small-cell lung cancer	Ou S.-H.I.;Zeaiter A;Golding S;Bordogna W;Han J.-Y;Chih-Hsin Yang;Tessmer A;Dansin E;De Pas T;Crino L;Duruisseaux M;Moro-Sibilot D.L;Chiappori A;Kim D.-W;De Petris L;Camidge D.R;Socinski M.A;Gandhi L;Govindan R;Shaw A.T;Gadgeel S.M; Gadgeel S.M; Shaw A.T; Govindan R; Gandhi L; Socinski M.A; Camidge D.R; De Petris L; Kim D.-W; Chiappori A; Moro-Sibilot D.L; Duruisseaux M; Crino L; De Pas T; Dansin E; Tessmer A; CHIH-HSIN YANG; Han J.-Y; Bordogna W; Golding S; Zeaiter A; Ou S.-H.I.
臺大學術典藏	2020-05-26T09:26:36Z	Pooled Systemic Efficacy and Safety Data from the Pivotal Phase II Studies (NP28673 and NP28761) of Alectinib in ALK-positive Non-Small Cell Lung Cancer	Shaw A.T.;Zeaiter A;Morcos P.N;Balas B;Bordogna W;Golding S;Dansin E;Ahn J.S;Popat S;Lena H;Crino L;Dingemans A.-M.C;Govindan R;Barlesi F;Kim D.-W;Gandhi L;Gadgeel S;De Petris L;Ou S.-H.I;Chih-Hsin Yang; CHIH-HSIN YANG; Ou S.-H.I; De Petris L; Gadgeel S; Gandhi L; Kim D.-W; Barlesi F; Govindan R; Dingemans A.-M.C; Crino L; Lena H; Popat S; Ahn J.S; Dansin E; Golding S; Bordogna W; Balas B; Morcos P.N; Zeaiter A; Shaw A.T.
臺大學術典藏	2020-05-26T09:26:36Z	Pooled Systemic Efficacy and Safety Data from the Pivotal Phase II Studies (NP28673 and NP28761) of Alectinib in ALK-positive Non-Small Cell Lung Cancer	Shaw A.T.;Zeaiter A;Morcos P.N;Balas B;Bordogna W;Golding S;Dansin E;Ahn J.S;Popat S;Lena H;Crino L;Dingemans A.-M.C;Govindan R;Barlesi F;Kim D.-W;Gandhi L;Gadgeel S;De Petris L;Ou S.-H.I;Chih-Hsin Yang; CHIH-HSIN YANG; Ou S.-H.I; De Petris L; Gadgeel S; Gandhi L; Kim D.-W; Barlesi F; Govindan R; Dingemans A.-M.C; Crino L; Lena H; Popat S; Ahn J.S; Dansin E; Golding S; Bordogna W; Balas B; Morcos P.N; Zeaiter A; Shaw A.T.
臺大學術典藏	2020-05-26T09:26:36Z	Efficacy of alectinib in central nervous system metastases in crizotinib-resistant ALK-positive non?�small-cell lung cancer: Comparison of RECIST 1.1 and RANO-HGG criteria	Gadgeel S.;Kotb A;Zeaiter A;Bordogna W;Golding S;Do P;L?na H;Crino L;De Castro J;Chih-Hsin Yang;Hughes B.G.M;Camidge D.R;Kim D.-W;Dingemans A.-M.C;Barlesi F;Shaw A.T;Ignatius Ou S.-H;Gandhi L; Gandhi L; Ignatius Ou S.-H; Shaw A.T; Barlesi F; Dingemans A.-M.C; Kim D.-W; Camidge D.R; Hughes B.G.M; CHIH-HSIN YANG; de Castro J; Crino L; Léna H; Do P; Golding S; Bordogna W; Zeaiter A; Kotb A; Gadgeel S.
臺大學術典藏	2020-05-26T09:26:36Z	Efficacy of alectinib in central nervous system metastases in crizotinib-resistant ALK-positive non?�small-cell lung cancer: Comparison of RECIST 1.1 and RANO-HGG criteria	Gadgeel S.;Kotb A;Zeaiter A;Bordogna W;Golding S;Do P;L?na H;Crino L;De Castro J;Chih-Hsin Yang;Hughes B.G.M;Camidge D.R;Kim D.-W;Dingemans A.-M.C;Barlesi F;Shaw A.T;Ignatius Ou S.-H;Gandhi L; Gandhi L; Ignatius Ou S.-H; Shaw A.T; Barlesi F; Dingemans A.-M.C; Kim D.-W; Camidge D.R; Hughes B.G.M; CHIH-HSIN YANG; de Castro J; Crino L; Léna H; Do P; Golding S; Bordogna W; Zeaiter A; Kotb A; Gadgeel S.
臺大學術典藏	2020-04-10T12:51:07Z	Dose escalation to rash for erlotinib plus gemcitabine for metastatic pancreatic cancer: The phase II RACHEL study	Van Cutsem E.; Li C.-P.; Nowara E.; Aprile G.; Moore M.; Federowicz I.; Van Laethem J.-L.; Chiun Hsu; Tham C.K.; Stemmer S.M.; Lipp R.; Zeaiter A.; Fittipaldo A.; Csutor Z.; Klughammer B.; Meng X.; Ciuleanu T.
臺大學術典藏	2014	Dose escalation to rash for erlotinib plus gemcitabine for metastatic pancreatic cancer: The phase II RACHEL study	Ciuleanu T.; Klughammer B.; Meng X.; Csutor Z.; Fittipaldo A.; Zeaiter A.; Lipp R.; Stemmer S.M.; CHIUN HSU; Tham C.K.; Van Cutsem E.; Li C.-P.; Nowara E.; Aprile G.; Moore M.; Federowicz I.; Van Laethem J.-L.

显示项目 1-10 / 10 (共1页)
1
每页显示[10|25|50]项目